Fluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer

Once-daily, oral levofloxacin monotherapy for low-risk neutropenic fever in cancer patients

(2015) Lixian He et al.   ANTI-CANCER DRUGS

Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy—EORTC Infectious Diseases Group Trial XV

(2013) Winfried V. Kern et al.   JOURNAL OF CLINICAL ONCOLOGY

Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline

(2013) Christopher R. Flowers et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of American Society of Clinical Oncology in Low- and Middle-Income Countries

(2011) Jyoti D. Patel et al.   JOURNAL OF CLINICAL ONCOLOGY

Safety of Early Discharge for Low-Risk Patients With Febrile Neutropenia: A Multicenter Randomized Controlled Trial

(2011) James A. Talcott et al.   JOURNAL OF CLINICAL ONCOLOGY

Predicting Adverse Events in Children With Fever and Chemotherapy-Induced Neutropenia: The Prospective Multicenter SPOG 2003 FN Study

(2010) Roland A. Ammann et al.   JOURNAL OF CLINICAL ONCOLOGY

Evidence-based medicine in China

(2010) Jiyao Wang   LANCET

Antibiotic resistance in China—a major future challenge

(2009) Andreas Heddini et al.   LANCET

Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution

(2008) C. Cattaneo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Outcomes and Cost of Outpatient or Inpatient Management of 712 Patients With Febrile Neutropenia

(2008) Linda S. Elting et al.   JOURNAL OF CLINICAL ONCOLOGY

Emergence and control of infectious diseases in China

(2008) Longde Wang et al.   LANCET